[14] Folate levels may modify the presentation of symptoms and disease course
CMap analysis has identified over 4,048 genes modulated by this compound
[5] Serum 25-hydroxyvitamin D, calcium, phosphate, and parathyroid hormone are re-examined at least eight weeks after each injection, and maintenance may shift to oral 1,000-2,000 IU daily once target levels (generally 30-50 ng mL ) are achieved, thereby reducing the risk of cumulative overdose while safeguarding skeletal health
Early trial results have been very promising, showing potential for even more substantial weight loss
Pal M, Lace B, Labrie Y, Laflamme N, Rioux N, Setty ST, et al